Exclusive Interview with Michael Hercz, General Counsel and Chief Compliance Officer
Complete the form below to unlock:
- Rare Disease Pharmaceutical insights from Sentynl Therapeutics' General Counsel with 28+ years of industry experience
- Compliance Strategies for Small Pharma Companies facing complex regulatory environments
- Career journey wisdom from legal practice to executive leadership in the biopharmaceutical sector